Variant report

Variant	esv3426241
Chromosome Location	chr6:24358398-24360946
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr6:24358029-24358618	HepG2	liver:	n/a	n/a
2	ATF2	chr6:24359869-24360519	H1-hESC	embryonic stem cell:	n/a	n/a
3	ATF2	chr6:24359864-24360689	H1-hESC	embryonic stem cell:	n/a	n/a
4	ATF3	chr6:24359812-24360261	H1-hESC	embryonic stem cell:	n/a	n/a
5	ATF3	chr6:24359958-24360193	K562	blood:	n/a	n/a
6	BACH1	chr6:24359901-24360651	H1-hESC	embryonic stem cell:	n/a	n/a
7	BCL3	chr6:24360011-24360666	A549	lung:	n/a	chr6:24360281-24360294
8	BCL3	chr6:24359831-24360595	A549	lung:	n/a	chr6:24360281-24360294
9	BCLAF1	chr6:24359951-24360369	GM12878	blood:	n/a	chr6:24360281-24360294
10	BHLHE40	chr6:24359925-24360287	K562	blood:	n/a	chr6:24360100-24360121
11	BHLHE40	chr6:24359895-24360519	GM12878	blood:	n/a	chr6:24360100-24360121
12	BHLHE40	chr6:24359918-24360404	A549	lung:	n/a	chr6:24360100-24360121
13	BRCA1	chr6:24359887-24360486	H1-hESC	embryonic stem cell:	n/a	n/a
14	CEBPB	chr6:24358231-24358476	HepG2	liver:	n/a	chr6:24358379-24358390
15	CEBPB	chr6:24358031-24358579	A549	lung:	n/a	chr6:24358379-24358390
16	CEBPB	chr6:24357963-24358684	MCF-7	breast:	n/a	chr6:24358379-24358390
17	CEBPB	chr6:24358051-24358632	A549	lung:	n/a	chr6:24358379-24358390
18	CEBPB	chr6:24359976-24360268	H1-hESC	embryonic stem cell:	n/a	n/a
19	CEBPB	chr6:24358260-24358666	HepG2	liver:	n/a	chr6:24358379-24358390
20	CEBPB	chr6:24358209-24358576	HepG2	liver:	n/a	chr6:24358379-24358390
21	CEBPD	chr6:24358053-24358402	HepG2	liver:	n/a	n/a
22	CHD2	chr6:24360842-24360889	GM12878	blood:	n/a	n/a
23	CHD2	chr6:24359993-24360539	GM12878	blood:	n/a	n/a
24	CHD2	chr6:24359841-24360548	H1-hESC	embryonic stem cell:	n/a	n/a
25	CREB1	chr6:24357452-24358653	HepG2	liver:	n/a	n/a
26	CREB1	chr6:24359921-24360628	A549	lung:	n/a	n/a
27	CREB1	chr6:24357777-24358405	A549	lung:	n/a	n/a
28	CREB1	chr6:24359879-24360416	H1-hESC	embryonic stem cell:	n/a	n/a
29	CREB1	chr6:24359816-24360665	H1-hESC	embryonic stem cell:	n/a	n/a
30	CTCF	chr6:24360040-24360190	HCT-116	colon:	n/a	chr6:24360076-24360089 chr6:24360074-24360092 chr6:24360076-24360089 chr6:24360075-24360091
31	CTCF	chr6:24360020-24360170	GM12873	blood:	n/a	chr6:24360076-24360089 chr6:24360074-24360092 chr6:24360076-24360089 chr6:24360075-24360091
32	CTCF	chr6:24360000-24360150	HL-60	blood:	n/a	chr6:24360076-24360089 chr6:24360074-24360092 chr6:24360076-24360089 chr6:24360075-24360091
33	CTCF	chr6:24359960-24360110	AG10803	skin:	n/a	chr6:24360076-24360089 chr6:24360074-24360092 chr6:24360076-24360089 chr6:24360075-24360091
34	CTCF	chr6:24359906-24360284	GM19239	blood:	n/a	chr6:24360076-24360089 chr6:24360074-24360092 chr6:24360076-24360089 chr6:24360075-24360091
35	CTCF	chr6:24360000-24360150	GM12801	blood:	n/a	chr6:24360076-24360089 chr6:24360074-24360092 chr6:24360076-24360089 chr6:24360075-24360091
36	CTCF	chr6:24360040-24360190	NHDF-neo	bronchial:	n/a	chr6:24360076-24360089 chr6:24360074-24360092 chr6:24360076-24360089 chr6:24360075-24360091
37	CTCF	chr6:24359980-24360130	AoAF	blood vessel:	n/a	chr6:24360076-24360089 chr6:24360074-24360092 chr6:24360076-24360089 chr6:24360075-24360091
38	CTCF	chr6:24360000-24360150	GM06990	blood:	n/a	chr6:24360076-24360089 chr6:24360074-24360092 chr6:24360076-24360089 chr6:24360075-24360091
39	CTCF	chr6:24360340-24360490	SK-N-SH_RA	brain:	n/a	n/a
40	CTCF	chr6:24359982-24360231	Kidney_OC	kidney:	n/a	chr6:24360076-24360089 chr6:24360074-24360092 chr6:24360076-24360089 chr6:24360075-24360091
41	CTCF	chr6:24360000-24360150	GM12874	blood:	n/a	chr6:24360076-24360089 chr6:24360074-24360092 chr6:24360076-24360089 chr6:24360075-24360091
42	CTCF	chr6:24360000-24360150	HUVEC	blood vessel:	n/a	chr6:24360076-24360089 chr6:24360074-24360092 chr6:24360076-24360089 chr6:24360075-24360091
43	CTCF	chr6:24359918-24360335	MCF-7	breast:	n/a	chr6:24360076-24360089 chr6:24360074-24360092 chr6:24360076-24360089 chr6:24360075-24360091
44	CTCF	chr6:24360060-24360210	GM12865	blood:	n/a	chr6:24360076-24360089 chr6:24360074-24360092 chr6:24360076-24360089 chr6:24360075-24360091
45	CTCF	chr6:24359940-24360090	GM12873	blood:	n/a	chr6:24360076-24360089 chr6:24360076-24360089
46	CTCF	chr6:24359980-24360130	HPAF	blood vessel:	n/a	chr6:24360076-24360089 chr6:24360074-24360092 chr6:24360076-24360089 chr6:24360075-24360091
47	CTCF	chr6:24359987-24360230	Pancreas_OC	pancreas:	n/a	chr6:24360076-24360089 chr6:24360074-24360092 chr6:24360076-24360089 chr6:24360075-24360091
48	CTCF	chr6:24359929-24360206	HUVEC	blood vessel:	n/a	chr6:24360076-24360089 chr6:24360074-24360092 chr6:24360076-24360089 chr6:24360075-24360091
49	CTCF	chr6:24359989-24360184	A549	lung:	n/a	chr6:24360076-24360089 chr6:24360074-24360092 chr6:24360076-24360089 chr6:24360075-24360091
50	CTCF	chr6:24360000-24360150	GM12869	blood:	n/a	chr6:24360076-24360089 chr6:24360074-24360092 chr6:24360076-24360089 chr6:24360075-24360091

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr6:24360603-24360653	T-47D	breast:	n/a
2	chr6:24360603-24360653	T-47D	breast:	n/a
3	chr6:24358683-24358733	HUVEC	blood vessel:	n/a
4	chr6:24360391-24360441	HepG2	liver:	n/a
5	chr6:24358566-24358616	Caco-2	colon:	n/a
6	chr6:24358681-24358731	Jurkat	blood:	n/a
7	chr6:24360391-24360441	BE2_C	brain:	n/a
8	chr6:24360156-24360206	Jurkat	blood:	n/a
9	chr6:24358566-24358616	HAEpiC	amniotic membrane:	n/a
10	chr6:24358683-24358733	HCF	heart:	n/a
11	chr6:24360304-24360354	Jurkat	blood:	n/a
12	chr6:24360391-24360441	SKMC	muscle:	n/a
13	chr6:24358681-24358731	SK-N-SH	brain:	n/a
14	chr6:24358566-24358616	SK-N-MC	brain:	n/a
15	chr6:24360304-24360354	AG09309	skin:	n/a
16	chr6:24360156-24360206	K562	blood:	n/a
17	chr6:24358566-24358616	HRE	kidney:	n/a
18	chr6:24358681-24358731	NH-A	brain:	n/a
19	chr6:24360304-24360354	A549	lung:	n/a
20	chr6:24358566-24358616	AG04450	lung:	fetal
21	chr6:24358566-24358616	HPAEpiC	pulmonary alveolar:	n/a
22	chr6:24360156-24360206	ECC-1	luminal epithelium:	n/a
23	chr6:24360603-24360653	NT2-D1	testis:	n/a
24	chr6:24358566-24358616	SK-N-SH_RA	brain:	n/a
25	chr6:24360156-24360206	HCM	heart:	n/a
26	chr6:24360304-24360354	AG09319	gingival:	n/a
27	chr6:24358681-24358731	GM06990	blood:	n/a
28	chr6:24360603-24360653	HEK293	kidney:	embryo
29	chr6:24358566-24358616	GM12878	blood:	n/a
30	chr6:24360156-24360206	LNCaP	prostate:	n/a
31	chr6:24360603-24360653	SKMC	muscle:	n/a
32	chr6:24360156-24360206	ovcar-3	ovarian:	n/a
33	chr6:24360391-24360441	HL-60	blood:	n/a
34	chr6:24358566-24358616	LNCaP	prostate:	n/a
35	chr6:24358566-24358616	NHDF-neo	bronchial:	n/a
36	chr6:24360391-24360441	GM12892	blood:	n/a
37	chr6:24358566-24358616	BJ	skin:	n/a
38	chr6:24358566-24358616	SKMC	muscle:	n/a
39	chr6:24358566-24358616	PANC-1	pancreas:	n/a
40	chr6:24358566-24358616	U87	brain:	n/a
41	chr6:24360304-24360354	HMEC	breast:	n/a
42	chr6:24358683-24358733	HCM	heart:	n/a
43	chr6:24360304-24360354	AoSMC	blood vessel:	n/a
44	chr6:24358683-24358733	PFSK-1	brain:	n/a
45	chr6:24360603-24360653	MCF-7	breast:	n/a
46	chr6:24360391-24360441	Jurkat	blood:	n/a
47	chr6:24358681-24358731	HRCEpiC	kidney:	n/a
48	chr6:24360603-24360653	GM12891	blood:	n/a
49	chr6:24360391-24360441	Caco-2	colon:	n/a
50	chr6:24360304-24360354	HL-60	blood:	n/a

No.	Distal block	Cell Line	Cell type
1	chr6:24282994..24284064-chr6:24359605..24360545,4	MCF-7	breast:
2	chr6:24360427..24362179-chr6:24370310..24373267,2	MCF-7	breast:
3	chr6:24281775..24284260-chr6:24359000..24360636,2	MCF-7	breast:
4	chr6:24283175..24284815-chr6:24359561..24361041,12	MCF-7	breast:
5	chr6:24341482..24343826-chr6:24359222..24360846,2	MCF-7	breast:

Variant related genes	Relation type
DCDC2	TF binding region
RNU6-391P	TF binding region
DCDC2	CpG island
RNU6-391P	CpG island

Extended variants
information (count: 142 )
Associated
traits (count: 102 )

Variant overlapped rSNPs/rCNVs (count:142 , 50 per page) page: 1 2 3

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs555807130	chr6:24358419-24358420	Weak transcription Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Active TSS Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
2	rs1277349	chr6:24358483-24358484	Weak transcription Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Active TSS Enhancers	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
3	rs539874761	chr6:24358505-24358506	Weak transcription Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Active TSS Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
4	rs576606721	chr6:24358512-24358513	Weak transcription Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Active TSS Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
5	rs145356111	chr6:24358516-24358517	Weak transcription Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Active TSS Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
6	rs545582302	chr6:24358518-24358519	Weak transcription Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Active TSS Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
7	rs180671206	chr6:24358530-24358531	Weak transcription Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Active TSS Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
8	rs531405850	chr6:24358551-24358552	Weak transcription Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Active TSS Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
9	rs548439076	chr6:24358557-24358558	Weak transcription Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Active TSS Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
10	rs374684644	chr6:24358567-24358568	Weak transcription Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Active TSS Enhancers	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
11	rs116141266	chr6:24358577-24358578	Weak transcription Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Active TSS Enhancers	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
12	rs184911892	chr6:24358578-24358579	Weak transcription Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Active TSS Enhancers	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
13	rs150997947	chr6:24358633-24358634	Weak transcription Bivalent/Poised TSS Bivalent Enhancer Enhancers Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
14	rs555434016	chr6:24358670-24358671	Weak transcription Bivalent/Poised TSS Bivalent Enhancer Enhancers Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
15	rs576417223	chr6:24358682-24358683	Weak transcription Bivalent/Poised TSS Bivalent Enhancer Enhancers Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
16	rs368783603	chr6:24358716-24358717	Weak transcription Bivalent/Poised TSS Bivalent Enhancer Enhancers Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
17	rs80308418	chr6:24358765-24358766	Weak transcription Bivalent/Poised TSS Bivalent Enhancer Enhancers Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
18	rs377348772	chr6:24358777-24358778	Weak transcription Bivalent/Poised TSS Bivalent Enhancer Enhancers Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
19	rs559014399	chr6:24358792-24358793	Weak transcription Bivalent/Poised TSS Bivalent Enhancer Enhancers Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
20	rs539981085	chr6:24358830-24358831	Weak transcription Bivalent Enhancer Bivalent/Poised TSS Enhancers Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
21	rs574522134	chr6:24358846-24358847	Weak transcription Bivalent Enhancer Bivalent/Poised TSS Enhancers Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
22	rs550017626	chr6:24358883-24358884	Weak transcription Bivalent Enhancer Bivalent/Poised TSS Enhancers Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
23	rs570203359	chr6:24358899-24358900	Weak transcription Bivalent Enhancer Bivalent/Poised TSS Enhancers Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
24	rs1277348	chr6:24358915-24358916	Weak transcription Bivalent Enhancer Bivalent/Poised TSS Enhancers Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
25	rs576969706	chr6:24358919-24358920	Weak transcription Bivalent Enhancer Bivalent/Poised TSS Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
26	rs201921328	chr6:24358927-24358928	Weak transcription Bivalent Enhancer Bivalent/Poised TSS Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
27	rs200285297	chr6:24358928-24358929	Weak transcription Bivalent Enhancer Bivalent/Poised TSS Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
28	rs74542811	chr6:24358930-24358931	Weak transcription Bivalent Enhancer Bivalent/Poised TSS Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
29	rs556009246	chr6:24358933-24358934	Weak transcription Bivalent Enhancer Bivalent/Poised TSS Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
30	rs13200182	chr6:24358935-24358936	Weak transcription Bivalent Enhancer Bivalent/Poised TSS Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
31	rs140906962	chr6:24358940-24358941	Weak transcription Bivalent Enhancer Bivalent/Poised TSS Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
32	rs533538323	chr6:24358943-24358944	Weak transcription Bivalent Enhancer Bivalent/Poised TSS Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
33	rs13216431	chr6:24358945-24358946	Weak transcription Bivalent Enhancer Bivalent/Poised TSS Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
34	rs13200187	chr6:24358948-24358949	Weak transcription Bivalent Enhancer Bivalent/Poised TSS Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
35	rs376236241	chr6:24358979-24358980	Weak transcription Bivalent Enhancer Bivalent/Poised TSS Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
36	rs35862154	chr6:24358980-24358981	Weak transcription Bivalent Enhancer Bivalent/Poised TSS Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
37	rs56771882	chr6:24358982-24358983	Weak transcription Bivalent Enhancer Bivalent/Poised TSS Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
38	rs7770890	chr6:24358983-24358984	Weak transcription Bivalent Enhancer Bivalent/Poised TSS Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
39	rs61617172	chr6:24359022-24359023	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
40	rs7770924	chr6:24359047-24359048	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
41	rs13216633	chr6:24359049-24359050	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
42	rs61207447	chr6:24359053-24359054	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
43	rs370918502	chr6:24359055-24359056	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
44	rs377077797	chr6:24359063-24359064	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
45	rs10634203	chr6:24359065-24359066	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
46	rs373385341	chr6:24359067-24359068	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
47	rs13216641	chr6:24359071-24359072	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
48	rs374518377	chr6:24359075-24359076	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
49	rs368799728	chr6:24359079-24359080	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
50	rs370058623	chr6:24359080-24359081	Weak transcription	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:102)

Disease	PMID	Source
Colorectal cancer	21297112	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Follicular lymphoma	20505157	CNVD
Glioblastoma multiforme	21080181	CNVD
Ewing''s sarcoma	21437220	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Leukemia	21518781	CNVD
Cancer	21637783	CNVD
Facial dysmorphism	22105932	CNVD
Medulloblastoma	21979893	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Diffuse large b-cell lymphoma	18287131	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	19960244	CNVD
Hepatocellular carcinoma	22174799	CNVD
Endometrial cancer	22040021	CNVD
Acute myeloid leukemia	16864856	CNVD
Breast cancer	21264507	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Cancer	16751803	CNVD
Bladder cancer	19088036	CNVD
Wilms tumour	21544195	CNVD
Uveal melanoma	21693616	CNVD
Biliary cancer	19435499	CNVD
Malaria	21533027	CNVD
Retinoblastoma	19183342	CNVD
Acute myeloid leukemia	20729466	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Breast cancer	20668451	CNVD
Cancer	20668451	CNVD
Lung cancer	20668451	CNVD
Ovarian cancer	20668451	CNVD
Pancreas cancer	20668451	CNVD
Prostate cancer	20668451	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Prostate cancer	18632612	CNVD
Myelodysplastic syndrome	21251322	CNVD
Breast cancer	21858162	CNVD
Lung cancer	18438408	CNVD
Multiple myeloma	17550852	CNVD
Ewing''s sarcoma	17952124	CNVD
Gastric cancer	16891809	CNVD
Ovarian cancer	21781307	CNVD
Autism	21448237	CNVD
Cancer	20164919	CNVD
Melanoma	18172304	CNVD
Breast cancer	22844521	CNVD
HIV/AIDS	22844521	CNVD
Ovarian cancer	22844521	CNVD
Prostate cancer	22844521	CNVD
Psoriasis	22844521	CNVD
Rheumatoid arthritis	22844521	CNVD
Sclerosis systemic	22844521	CNVD
Systemic lupus erythematosus	22844521	CNVD
Breast cancer	22522925	CNVD
Breast cancer	21552322	CNVD
Immune disease	21076436	CNVD
Autoimmune disease	19135723	CNVD
Systemic lupus erythematosus	17953491	CNVD
Recurrent Infections	22737222	CNVD
Systemic lupus erythematosus	21904924	CNVD
Ependymoma	19289631	CNVD
Gestational infection	22844521	CNVD
Head circumference	22844521	CNVD
Infertility	22844521	CNVD
Recurrent birth weight diabetes	22844521	CNVD
Obesity	22844521	CNVD
Recurrent pregnancy loss	22844521	CNVD
Intellectual disability	21811512	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Congenital anomalies of the kidney and urinary tract	18694510	CNVD
Nasopharyngeal cancer	22815911	CNVD
Osteosarcoma	16790693	CNVD
Hepatocellular carcinoma	16750200	CNVD
Basal cell lymphoma	21115979	CNVD
Acute lymphoblastic leukemia	21339820	CNVD
Breast cancer	17133270	CNVD
Autism	22495311	CNVD
Burkitt''s lymphoma	19759907	CNVD
T-cell prolymphocytic leukemia	17713554	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Cancer	16790693	CNVD
Breast cancer	22032731	CNVD
Cervical cancer	21062161	CNVD
Breast cancer	21785460	CNVD
Bladder cancer	16790693	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Retinoblastoma	16790693	CNVD
Esophageal adenocarcinoma	18820669	CNVD
Systemic lupus erythematosus	17503323	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
T-cell lymphomas	19863542	CNVD
Urothelial carcinoma	18382360	CNVD
Lung cancer	19153074	CNVD
Breast cancer	21364760	CNVD
Cancer	21183584	CNVD
Myelofibrosis	22110671	CNVD
Williams-beuren syndrome	16971481	CNVD
Uveal melanoma	20484589	CNVD
small cell lung cancer	20016488	CNVD
Pancreatic cancer	17952125	CNVD

Chromatin state (count:542 , 50 per page) page: 1 2 3 4 5 6 7 ... 11

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr6:24353200-24358800	Active TSS	Fetal Kidney	kidney
2	chr6:24354200-24358800	Active TSS	Pancreatic Islets	Pancreatic Islet
3	chr6:24354800-24358800	Active TSS	A549	lung
4	chr6:24356800-24358400	Bivalent/Poised TSS	Fetal Lung	lung
5	chr6:24357000-24358400	Bivalent/Poised TSS	HUES6 Cell Line	embryonic stem cell
6	chr6:24357000-24358400	Bivalent/Poised TSS	HepG2	liver
7	chr6:24357000-24358600	Active TSS	Fetal Intestine Small	intestine
8	chr6:24357400-24358800	Bivalent/Poised TSS	iPS-15b Cell Line	embryonic stem cell
9	chr6:24357400-24358800	Flanking Bivalent TSS/Enh	Foreskin Keratinocyte Primary Cells skin03	Skin
10	chr6:24357400-24359800	Weak transcription	H9 Derived Neuron Cultured Cells	ES cell derived
11	chr6:24357600-24358400	ZNF genes & repeats	H1 Derived Mesenchymal Stem Cells	ES cell derived
12	chr6:24357600-24358400	Bivalent/Poised TSS	iPS-20b Cell Line	embryonic stem cell
13	chr6:24357600-24358600	Bivalent/Poised TSS	HUES48 Cell Line	embryonic stem cell
14	chr6:24357600-24358600	Active TSS	Primary T cells effector/memory enriched fromperipheralblood	blood
15	chr6:24357600-24358600	Flanking Bivalent TSS/Enh	Foreskin Fibroblast Primary Cells skin01	Skin
16	chr6:24357600-24358600	Flanking Bivalent TSS/Enh	Foreskin Keratinocyte Primary Cells skin02	Skin
17	chr6:24357600-24358800	Active TSS	Rectal Smooth Muscle	rectum
18	chr6:24357600-24358800	Enhancers	Spleen	Spleen
19	chr6:24357800-24358400	Active TSS	H9 Cell Line	embryonic stem cell
20	chr6:24357800-24358400	Bivalent/Poised TSS	iPS DF 6.9 Cell Line	embryonic stem cell
21	chr6:24357800-24358400	Flanking Bivalent TSS/Enh	iPS DF 19.11 Cell Line	embryonic stem cell
22	chr6:24357800-24358400	Flanking Active TSS	ES-UCSF4 Cell Line	embryonic stem cell
23	chr6:24357800-24358400	Flanking Bivalent TSS/Enh	Primary hematopoietic stem cells	blood
24	chr6:24357800-24358400	Active TSS	Primary T helper memory cells from peripheral blood 2	blood
25	chr6:24357800-24358400	Active TSS	Primary T helper naive cells from peripheral blood	blood
26	chr6:24357800-24358400	Active TSS	Primary T helper naive cells fromperipheralblood	blood
27	chr6:24357800-24358400	Active TSS	Primary T killer memory cells from peripheral blood	blood
28	chr6:24357800-24358400	Flanking Bivalent TSS/Enh	Cortex derived primary cultured neurospheres	brain
29	chr6:24357800-24358400	Flanking Bivalent TSS/Enh	Foreskin Fibroblast Primary Cells skin02	Skin
30	chr6:24357800-24358400	Active TSS	Brain Angular Gyrus	brain
31	chr6:24357800-24358400	Flanking Active TSS	Colonic Mucosa	Colon
32	chr6:24357800-24358400	Bivalent Enhancer	Fetal Brain Male	brain
33	chr6:24357800-24358400	Flanking Active TSS	Gastric	stomach
34	chr6:24357800-24358400	Flanking Active TSS	Lung	lung
35	chr6:24357800-24358400	Flanking Active TSS	Ovary	ovary
36	chr6:24357800-24358400	Flanking Bivalent TSS/Enh	NH-A	brain
37	chr6:24357800-24358600	Bivalent/Poised TSS	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
38	chr6:24357800-24358600	Flanking Active TSS	Primary B cells from peripheral blood	blood
39	chr6:24357800-24358600	Flanking Active TSS	Foreskin Melanocyte Primary Cells skin03	Skin
40	chr6:24357800-24358600	Bivalent/Poised TSS	Primary mononuclear cells fromperipheralblood	Blood
41	chr6:24357800-24358600	Flanking Active TSS	Liver	Liver
42	chr6:24357800-24358600	Active TSS	Brain Inferior Temporal Lobe	brain
43	chr6:24357800-24358600	Active TSS	Brain Dorsolateral Prefrontal Cortex	brain
44	chr6:24357800-24358600	Flanking Active TSS	Skeletal Muscle Male	skeletal muscle
45	chr6:24357800-24358600	Flanking Active TSS	Skeletal Muscle Female	skeletal muscle
46	chr6:24357800-24358600	Active TSS	GM12878-XiMat	blood
47	chr6:24357800-24358800	Flanking Bivalent TSS/Enh	Primary T cells fromperipheralblood	blood
48	chr6:24357800-24358800	Flanking Bivalent TSS/Enh	Primary hematopoietic stem cells G-CSF-mobilized Female	--
49	chr6:24357800-24358800	Flanking Bivalent TSS/Enh	Primary hematopoietic stem cells G-CSF-mobilized Male	--
50	chr6:24358000-24358400	Active TSS	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links